(Q71568237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

multiple endocrine neoplasia type 2

19 October 2019

main subject

1 reference

familial medullary thyroid carcinoma

inferred from title

1 reference

5

C E Broelsch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

A Frilling

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

H Dralle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

C Eng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

F Raue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

1 reference

1 December 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

1099-103; discussion 1103-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Risk estimation and screening in families of patients with medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2805%2980120-5

7 January 2021

10.1016/S0039-6060(05)80120-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7491529%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference